Latest Financial Health News

Alterity Therapeutics reports strengthened efficacy signals for ATH434 in Multiple System Atrophy and secures a robust cash position to fuel upcoming Phase 3 trials.

PainChek has secured FDA De Novo clearance for its Adult App, opening immediate access to a $175 million AUD US long-term care market and advancing its Infant App commercialization targeting a $15 billion AUD global opportunity.

ACDC Metals reports promising mineralogy results from its Goschen Central Project, highlighting valuable rare earth elements and heavy minerals. The company maintains a solid cash balance and advances its retention licence application, positioning itself well in the evolving rare earth sector.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.

Articore Group has initiated an on-market share buy-back of up to 10% of its issued capital, signaling renewed confidence in its turnaround and long-term growth prospects.

Humm Group reports a 14% decline in new loan originations for 1Q26, driven by a steep 61% fall in Australian Point of Sale volumes following regulatory changes and technology setbacks. However, international growth and asset expansion provide some offset.

Narryer Metals advances metallurgical studies at Rocky Gully, revealing a promising dual-path processing flowsheet and a 124% uplift in rare earth grades, while also announcing a significant new titanium discovery at its Muckanippie JV in South Australia.

Norfolk Metals has kicked off its maiden drilling campaign at the Carmen Copper Project in Chile, backed by a A$3.5 million capital raise and the strategic appointment of mining veteran David Fowler to its board.

Latitude 66 Ltd reported a net cash outflow of A$889,000 for Q3 2025 but strengthened its balance sheet by completing the sale of its Greater Duchess JV interest, securing A$2 million in cash and A$4 million in shares.

Nanoveu Limited has reported a major leap in drone endurance through its ultra-low-power AI chip technology, alongside advancing its next-generation 16 nm chip towards fabrication and expanding its U.S. sales network.

Nutritional Growth Solutions reported a 13% revenue increase in Q3 FY25, driven by expanded US retail distribution and inventory replenishment. The company raised AU$760k to support growth but faces a tight cash runway, banking on upcoming capital raises and retail momentum.

Icon Energy Limited holds steady with $294,000 cash as it awaits key regulatory decisions on ATP 855 renewal and Petroleum Lease PL-1144, facing a looming ASX suspension deadline.